透析患者心血管事件诊治进展  

Advances in the diagnosis and management of cardiovascular diseases in dialysis patients

作　　者：朱新旺[1] 徐天华[1] 姚丽[1] ZHU Xinwang;XU Tian-hua;YAO Li(Department of Nephrology,the First Hospital of China Medical University,Shenyang 110001,China)

机构地区：[1]中国医科大学附属第一医院肾内科,沈阳110001

出　　处：《中国血液净化》2021年第7期433-436,共4页Chinese Journal of Blood Purification

摘　　要：我国血液透析及腹膜透析患者数量逐年增多,透析患者心血管疾病(cardiovascular disease,CVD)高发且死亡率高。本文主要关注透析患者心血管事件包括冠状动脉粥样硬化性心脏病(coronary atherosclerotic disease,CAD)及心力衰竭。透析患者CAD诊治原则与非肾病患者相似,部分检查、治疗、用药的指征、效果和副作用具有透析患者的特异性。The number of hemodialysis and peritoneal dialysis patients increase yearly in China.The incidence of cardiovascular disease(CVD)is higher in dialysis patients,causing higher mortality in these patients.This article focuses on CVD,including coronary atherosclerotic heart disease and heart failure,in dialysis patients.The principles of diagnosis and management of CVD in dialysis patients are similar to those in non-renal patients.However,some of the examinations,treatment indicators and effects,and medication side effects are specific to dialysis patients.

关 键 词：血液透析 腹膜透析 心血管事件 冠状动脉粥样硬化性心脏病 心力衰竭 

分 类 号：R54[医药卫生—心血管疾病]